<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04101266</url>
  </required_header>
  <id_info>
    <org_study_id>59/13</org_study_id>
    <nct_id>NCT04101266</nct_id>
  </id_info>
  <brief_title>Pain Management in Shoulder Surgery</brief_title>
  <acronym>PMSS</acronym>
  <official_title>Comparison of the Effects Combined Suprascapular and Infraclavicular Nerve Blocks to Interscalene Nerve Block Applied Shoulder Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Yildirim Beyazit Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Yildirim Beyazit Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is compared that combined suprascapular and infraclavicular nerve blocks to interscalene
      nerve block for clinical outcomes after shoulder surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, the investigators planned to investigate postoperative pain, analgesic dosage,
      respiratory effects of the block and side effects of patients undergoing general anaesthesia
      after shoulder surgery under preoperative interscalene nerve block or suprascapular +
      infraclavicular nerve block.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 30, 2019</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain: numeric rating scale (NRS)</measure>
    <time_frame>postoperative 30. minute, 4. hour, 8.hour, 24. hour, 48. hour</time_frame>
    <description>postoperative pain will be evaluated by numeric rating scale (NRS) .</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Arthroscopic Shoulder Surgery</condition>
  <arm_group>
    <arm_group_label>Interscalene nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>preoperative interscalene nerve block to be applied with ultrasound guidance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>suprascapular and infraclavicular nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>preoperative suprascapular and infraclavicular nerve block to be with ultrasound guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interscalene block</intervention_name>
    <description>30 minutes before anaesthesia induction interscalene nerve block will be applied with ultrasound guidance with %0,025 bupivacain 20 cc .</description>
    <arm_group_label>Interscalene nerve block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>suprascapular and infraclavicular nerve block</intervention_name>
    <description>30 minutes before anaesthesia induction suprascapular with %0,025 bupivacain 10 cc .and infraclavicular nerve block with %0,025 bupivacain 10 cc will be applied with ultrasound guidance</description>
    <arm_group_label>suprascapular and infraclavicular nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective shoulder surgery under general anesthesia with
             suprascapular + infraclavicular nerve block or interscalene nerve block for any reason
             ASA 1-3 patients

        Exclusion Criteria:

          -  Diabetes

          -  coagulopathy

          -  local anesthetic allergy

          -  chronic opioid users

          -  advanced stage COPD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tuğba Arslan, MD</last_name>
    <phone>05074378919</phone>
    <email>tuba.kokulu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>tuğba arslan</last_name>
    <phone>05074378919</phone>
    <email>tuba.kokulu@gmail.com</email>
  </overall_contact_backup>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2019</study_first_posted>
  <last_update_submitted>September 23, 2019</last_update_submitted>
  <last_update_submitted_qc>September 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Yildirim Beyazit Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Tugba Arslan</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

